Biotech's Complex Moment: What's Next for Europe?
Biotech is growing more complex as companies race to source Asian assets for newcos in the West and geopolitical tensions challenge globalization, data sharing and cross-border talent exchange.
What's next for European biotech? Can it rise to the complexity of the moment? Can it match the growing competition and walk the fine line of geopolitics?
Celebrating its 25th year, Bio€quity Europe is the destination event for biopharma decision-makers to network, partner and debate critical issues facing the biotech industry.